Blackhill Capital’s Avanos Medical AVNS Stock Holding History

Blackhill Capital’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$33.3K	Hold	2,375	–	–	﹤0.01%	48
2025 Q4	$26.7K	Sell	2,375 -723	-23%	-$8.27K	﹤0.01%	49
2025 Q3	$35.8K	Hold	3,098	–	–	﹤0.01%	50
2025 Q2	$37.9K	Hold	3,098	–	–	﹤0.01%	48
2025 Q1	$44.4K	Hold	3,098	–	–	﹤0.01%	47
2024 Q4	$49.3K	Sell	3,098 -1,420	-31%	-$28.1K	﹤0.01%	46
2024 Q3	$109K	Hold	4,518	–	–	0.01%	47
2024 Q2	$90K	Hold	4,518	–	–	0.01%	48
2024 Q1	$90K	Hold	4,518	–	–	0.01%	48
2023 Q4	$101K	Sell	4,518 -1,155	-20%	-$23.8K	0.01%	48
2023 Q3	$115K	Hold	5,673	–	–	0.01%	47
2023 Q2	$145K	Hold	5,673	–	–	0.02%	47
2023 Q1	$169K	Hold	5,673	–	–	0.02%	47
2022 Q4	$154K	Sell	5,673 -944	-14%	-$23.1K	0.02%	48
2022 Q3	$144K	Hold	6,617	–	–	0.02%	45
2022 Q2	$181K	Hold	6,617	–	–	0.02%	44
2022 Q1	$222K	Hold	6,617	–	–	0.02%	47
2021 Q4	$229K	Sell	6,617 -819	-11%	-$26.5K	0.02%	49
2021 Q3	$232K	Hold	7,436	–	–	0.02%	48
2021 Q2	$270K	Hold	7,436	–	–	0.02%	47
2021 Q1	$325K	Hold	7,436	–	–	0.03%	45
2020 Q4	$341K	Sell	7,436 -475	-6%	-$19.8K	0.04%	46
2020 Q3	$263K	Hold	7,911	–	–	0.04%	44
2020 Q2	$233K	Hold	7,911	–	–	0.03%	45
2020 Q1	$213K	Hold	7,911	–	–	0.04%	48
2019 Q4	$267K	Sell	7,911 -577	-7%	-$20.9K	0.04%	52
2019 Q3	$318K	Hold	8,488	–	–	0.05%	54
2019 Q2	$370K	Hold	8,488	–	–	0.06%	49
2019 Q1	$362K	Hold	8,488	–	–	0.06%	51
2018 Q4	$380K	Sell	8,488 -436	-5%	-$22.8K	0.07%	47
2018 Q3	$611K	Hold	8,924	–	–	0.1%	45
2018 Q2	$511K	Hold	8,924	–	–	0.09%	46
2018 Q1	$411K	Hold	8,924	–	–	0.08%	48
2017 Q4	$412K	Sell	8,924 -427	-5%	-$19.6K	0.07%	48
2017 Q3	$421K	Hold	9,351	–	–	0.08%	47
2017 Q2	$367K	Hold	9,351	–	–	0.07%	49
2017 Q1	$356K	Hold	9,351	–	–	0.07%	51
2016 Q4	$346K	Sell	9,351 -2,574	-22%	-$92K	0.07%	50
2016 Q3	$413K	Hold	11,925	–	–	0.07%	49
2016 Q2	$388K	Hold	11,925	–	–	0.06%	50
2016 Q1	$343K	Hold	11,925	–	–	0.06%	51
2015 Q4	$398K	Hold	11,925	–	–	0.06%	50
2015 Q3	$339K	Sell	11,925 -37	-0.3%	-$1.29K	0.05%	51
2015 Q2	$484K	Hold	11,962	–	–	0.06%	48
2015 Q1	$589K	Sell	11,962 -1,250	-9%	-$57.9K	0.07%	45
2014 Q4	$601K	Buy	+13,212	New	+$519K	0.08%	44

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Blackhill Capital's AVNS Position: Q1 2026 in Review

Blackhill Capital held its Avanos Medical (AVNS) position steady in Q1 2026 at 2,375 shares worth $33.3K. The position accounts for ﹤0.01% of the portfolio, ranked #48.

Blackhill Capital first reported a position in AVNS in Q4 2014 and has held it in 46 quarters since. The position peaked at $611K in Q3 2018. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

Blackhill Capital held 2,375 shares of Avanos Medical worth $33.3K as of Q1 2026.
Blackhill Capital left its Avanos Medical share count unchanged in Q1 2026.
Avanos Medical made up ﹤0.01% of Blackhill Capital's portfolio in Q1 2026, its #48 holding.
Blackhill Capital first reported a position in Avanos Medical in Q4 2014 and has held it in 46 quarters since.
Blackhill Capital's Avanos Medical position peaked at $611K in Q3 2018.
257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Blackhill Capital's 13F filing for Q1 2026, filed 14 May 2026.